Arstasis Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Arstasis's estimated annual revenue is currently $7M per year.(i)
  • Arstasis's estimated revenue per employee is $251,000

Employee Data

  • Arstasis has 28 Employees.(i)
  • Arstasis grew their employee count by 0% last year.

Arstasis's People

NameTitleEmail/Phone
1
VP R/DReveal Email/Phone
2
Administrative Assistant/Event CoordinatorReveal Email/Phone
3
Customer Service RepresentativeReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M7920%N/AN/A
#2
$8.5M3111%N/AN/A
#3
$4.5M13-13%N/AN/A
#4
$8M25-4%N/AN/A
#5
$5.3M16-6%N/AN/A
#6
$54.2M163-8%N/AN/A
#7
$12M55-17%N/AN/A
#8
$10M30-9%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M43-7%N/AN/A
Add Company

What Is Arstasis?

Self-Sealing Access, Implant Free… Naturally. AXERA® Access seals securely using nothing but the femoral artery wall itself. AXERA® Access creates a long, shallow angle arteriotomy that delivers significant tissue-on-tissue overlap through the femoral artery wall. This creates a self-sealing opening that requires only minimal compression for rapid hemostasis and secure closure. Self-sealing access also provides excellent patient comfort and quick ambulation. And because AXERA® Access deposits no foreign material, it eliminates all implant related complications. Self-Sealing Access Benefits Demonstrated in RECITAL Study* - Significant decrease in manual compression time by half or more - Elevate bed to 45º within 15-30 minutes of hemostasis - Ambulate patients in 1 to 2 hours - No patient implant delivers excellent patient comfort and safety *AXERA 2 IFU, SECURE II and RECITAL clinical study summaries.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Arstasis News

2022-04-19 - Arterial Incision Closure Device Market 2022: Covid-19 Impact ...

... Competitive Landscape, Growth Factors, Top Venders and Forecast Till 2028 : Abbott, Cardinal Health, Arstasis, Cardiva Medical.

2022-04-17 - Global Arteriotomy Closure Devices Market 2022 Type ...

Global Arteriotomy Closure Devices Market 2022 Type, Application and Top Players – Abbott, Abbott, Cardinal Health, Arstasis, Cardiva Medical.

2022-04-17 - Global Arteriotomy Closure Devices Market 2022 Consumer ...

It also looks at the key industry vendors that are now accessible. Abbott; Abbott; Cardinal Health; Arstasis; Cardiva Medical; Vasorum. It...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7M28-3%N/A
#2
$3.5M28-3%N/A
#3
$3.2M288%N/A
#4
$1.6M2938%$77.4M
#5
$6.6M290%N/A